Predictive impact of soluble interleukin‐2 receptor and number of extranodal sites for identification of patients at very high risk of CNS relapse in diffuse large B‐cell lymphoma

Predictive impact of soluble interleukin‐2 receptor and number of extranodal sites for identification of patients at very high risk of CNS relapse in diffuse large B‐cell lymphoma

Abstract There remains an unmet clinical need to identify which patients with diffuse large B‐cell lymphoma (DLBCL) would benefit from central nervous system (CNS) prophylaxis, due to the low positive predictive value (PPV; 10%–15%) of the currently available predictive models. To stratify patients...

Full description

Bibliographic Details
Main Authors: Takafumi Shichijo, Hiro Tatetsu, Kisato Nosaka, Yusuke Higuchi, Yoshitaka Kikukawa, Yoshitaka Inoue, Kosuke Toyoda, Jun‐ichirou Yasunaga, Masao Matsuoka
Format: Article
Language:English
Published: Wiley 2022-05-01
Series:eJHaem
Subjects:
CNS relapse
CNS‐IPI
diffuse large B‐cell lymphoma
extranodal site
sIL‐2R
Online Access:https://doi.org/10.1002/jha2.393

Internet

https://doi.org/10.1002/jha2.393

Similar Items